Adenoid cystic carcinoma of the uterine cervix with metastasis 10 years postsurgery: Case report and literature review Authors: Yinping Han, Junlin Zhou Published: 2026 ABSTRACT Adenoid cystic carcinoma (ACC) of the uterine cervix is a rare primary malignancy. A 60-year-old woman presented with a >1 year history of intermittent upper abdominal pain and discomfort, which had worsened over the preceding 4 days. Ten years earlier, the patient presented with irregular vaginal bleeding. Pelvic ultrasonography revealed a homogeneous myometrium, a clearly defined endometrium, and an indistinct echo pattern in the endocervical canal; no significant abnormalities were detected in either adnexa. Endometrial curettage and pathological biopsy confirmed ACC of the uterine cervix. The patient subsequently underwent total hysterectomy with bilateral oophorectomy, but declined postoperative adjuvant chemotherapy or radiotherapy. During the current admission, contrast-enhanced computed tomography of the entire abdomen revealed multiple, round, and slightly hypodense lesions in the right hepatic lobe, most of which were located near the liver margin and exhibited mild peripheral enhancement. Multiple soft tissue nodules of varying size were noted in the peritoneum and greater omentum, exhibiting heterogeneous and marked enhancement. Contrast-enhanced computed tomography of the head, neck, and chest revealed no significant abnormalities. Finally, fine-needle aspiration biopsy of the peritoneal nodule was performed, and metastasis of ACC of the uterine cervix was diagnosed. Palliative treatment was initiated; however, the patient died of multiple organ failure 1 month after treatment. This case indicates that ACC of the uterine cervix may develop distant metastasis as late as 10 years after initial diagnosis without adjuvant radiotherapy or chemotherapy. Clinicians should raise awareness of this disease, strengthen long-term follow-up, and perform timely imaging evaluations when symptoms occur. Introduction Adenoid cystic carcinoma (ACC) of the uterine cervix is an extremely rare cervical malignancy featuring a high degree of malignancy and unique biological behavior. However, the limited number of relevant clinical studies and case reports has led to many difficulties in clinical diagnosis, treatment, and long-term follow-up management. The patient described in the present report was in the early stage of ACC and underwent radical hysterectomy plus bilateral oophorectomy. Multiple metastases in the peritoneum and liver occurred 10 years after surgery; however, this disease progression pattern is significantly different from that reported in the previous literature, which has some clinical reference value. However, details of the present case can deepen clinicians’ understanding of the special biological behavior of ACC of the uterine cervix, further improving standardized diagnosis and systematic treatment of this disease. Long-term, individualized follow-up strategies should be developed for patients with significantly prolonged follow-up periods. Comprehensive imaging examinations of the entire abdomen and chest should be performed regularly to continuously monitor the risk for tumor recurrence and distant metastasis, and to identify occult metastatic lesions as early as possible. Furthermore, this case also fully confirms that the risk for long-term delayed distant metastasis cannot be completely avoided after radical surgical resection for early stage ACC. Clinically, it is necessary to evaluate the indications and clinical utility of postoperative adjuvant radiotherapy and chemotherapy. Through standardized postoperative adjuvant therapy, the probability of long-term tumor recurrence and distant metastasis can be minimized, thereby improving the long-term survival of affected patients. Case report A 60-year-old woman was admitted to the authors’ hospital with a >1-year history of intermittent upper abdominal pain and discomfort, which had worsened over the previous 4 days. Physical examination revealed a surgical scar, measuring approximately 10 cm in length, on the lower abdomen. Ten years earlier, the patient presented with irregular vaginal bleeding. Pelvic ultrasonography revealed a homogeneous myometrium, a clearly defined endometrium, and an indistinct echo pattern in the endocervical canal; no significant abnormalities were detected in either adnexa. Endometrial curettage and pathological biopsy confirmed ACC in the uterine cervix. The patient subsequently underwent total hysterectomy with bilateral oophorectomy but declined postoperative adjuvant chemotherapy or radiotherapy. During the present admission, laboratory investigations revealed the following tumor marker levels: alpha-fetoprotein, 4.49 ng/mL; carcinoembryonic antigen (CEA) 3.78 ng/mL; cancer antigen (CA)125 62.15 U/mL; CA153 6.95 U/mL; and CA199 < 1 U/mL. Contrast-enhanced computed tomography (CT) of the entire abdomen revealed multiple, round, and slightly hypodense lesions in the right hepatic lobe, most of which were located near the liver margin and exhibited mild peripheral enhancement (Fig. 1). Multiple soft tissue nodules of varying size were noted in the peritoneum and greater omentum, exhibiting heterogeneous and marked enhancement (Figs. 2A–D). No significant abnormalities were observed on contrast-enhanced CT of the head, neck, or chest. Fine-needle aspiration biopsy of the peritoneal nodules was performed. Microscopic examination revealed sheets of atypically proliferating tumor cells within fibrous connective tissue. The tumor cells exhibited abundant eosinophilic cytoplasm, with some cells exhibiting clear cytoplasm and prominent nucleoli. They were arranged in cribriform, nested, atypical glandular, and tubular patterns, with peripheral palisading cells frequently observed around the tumor nests. Tumor emboli were present within the vascular lumen (Figs. 3A–D). Immunohistochemical staining revealed the following profile: CKP positive (+); CK7 (+); CK8/18 (+); vimentin (partially +); CK20 negative (–); CR (–); CD10 (–); CD34 (vascular structures +); GATA-3 (–); ER (–); PR (–); AR (focally weak +); TTF-1 (–); napsin A (–); WT-1 (–); P16 (focally weak +); P40 (–); PAX8 (–); and Ki-67 positivity of approximately 20% in hotspot areas (Fig. 4, Fig. 5, Fig. 6, Fig. 7). The tumor cells exhibited biphasic expression of epithelial markers (CKP, CK7, and CK8/18) and myoepithelial markers (vimentin), together with a relatively low Ki-67 proliferation index (20%). After excluding primary peritoneal malignant mesothelioma, malignant Müllerian mixed tumor, metastatic hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and malignant tumors originating from the uterus and adnexa (including endometrioid adenocarcinoma, high-grade serous carcinoma, clear-cell carcinoma, mucinous adenocarcinoma, and cervical mesonephric adenocarcinoma), the lesion was considered to be most consistent with a salivary gland-type malignancy. Accordingly, a final diagnosis of metastatic ACC was established.Fig. 1Contrast-enhanced computed tomography of the abdomen revealing multiple round, slightly hypodense lesions in the right hepatic lobe, most of which are located near the liver margin. Mild peripheral enhancement is evident along the lesion margins.Fig 1 dummy alt textFig. 2(A–D) Contrast-enhanced computed tomography images revealing multiple nodular soft-tissue lesions of varying size in the peritoneum and greater omentum, exhibiting moderate heterogeneous enhancement.Fig 2 dummy alt textFig. 3(A–D) Histopathological examination revealing sheets of atypical proliferating tumor cells within fibrous connective tissue. The tumor cells exhibit abundant eosinophilic cytoplasm, with some exhibiting clear cytoplasm and prominent nucleoli. The cells are arranged in cribriform, nested, atypical glandular, and tubular patterns, with peripheral palisading around tumor nests. Tumor emboli are apparent within the vascular lumina.Fig 3 dummy alt textFig. 4Immunohistochemical staining revealing CK7 positivity in tumor cells.Fig 4 dummy alt textFig. 5Immunohistochemical staining revealing CK8/18 positivity in tumor cells.Fig 5 dummy alt textFig. 6Immunohistochemical staining revealing CKP positivity in tumor cells.Fig 6 dummy alt textFig. 7Immunohistochemical staining revealing Ki-67 positivity in approximately 20% of tumor cells in hotspot regions.Fig 7 dummy alt text Contrast-enhanced computed tomography of the abdomen revealing multiple round, slightly hypodense lesions in the right hepatic lobe, most of which are located near the liver margin. Mild peripheral enhancement is evident along the lesion margins. (A–D) Contrast-enhanced computed tomography images revealing multiple nodular soft-tissue lesions of varying size in the peritoneum and greater omentum, exhibiting moderate heterogeneous enhancement. (A–D) Histopathological examination revealing sheets of atypical proliferating tumor cells within fibrous connective tissue. The tumor cells exhibit abundant eosinophilic cytoplasm, with some exhibiting clear cytoplasm and prominent nucleoli. The cells are arranged in cribriform, nested, atypical glandular, and tubular patterns, with peripheral palisading around tumor nests. Tumor emboli are apparent within the vascular lumina. Immunohistochemical staining revealing CK7 positivity in tumor cells. Immunohistochemical staining revealing CK8/18 positivity in tumor cells. Immunohistochemical staining revealing CKP positivity in tumor cells. Immunohistochemical staining revealing Ki-67 positivity in approximately 20% of tumor cells in hotspot regions. Discussion ACC is a rare neoplasm that most commonly occurs in the salivary glands. It is an extremely rare primary tumor of the uterine cervix, representing a variant of adenocarcinoma, with an incidence <1% [1]. This phenomenon was first reported by McGee et al. [2]. Although cervical ACC shares morphological features similar to those of salivary ACC, it usually lacks MYB gene rearrangement and is a high-grade malignant tumor with adenoid basal-like features [3]; however, its pathogenesis remains unclear. Studies have suggested that cervical ACC arises from cervical reserve cells, which are multipotent cells capable of differentiating into various tissues, including the squamous and glandular epithelia. High-risk human papillomavirus (HPV) infection has been implicated in carcinogenesis [3], with HPV type 16 being closely associated with ACC [4]. Therefore, some investigators have proposed that true ACC may not exist in the uterine cervix; instead, these tumors resemble HPV-related multi-phenotypic carcinomas of the head and neck with an “ACC-like” histological appearance [4]. Cervical ACC predominantly affects postmenopausal women; its typical clinical manifestation is irregular vaginal bleeding after menopause. The patient in this case was 50 years of age, tested positive for HPV type 16, and presented with abnormal vaginal bleeding, consistent with previously published reports. Cervical ACC is more aggressive than cervical squamous cell carcinoma, and has a high propensity for local recurrence and distant metastasis [5,6]. The 5- and 10-year survival rates are 37% and 40%, respectively [6]. A review of 43 patients with cervical ACC revealed that the 3- to 5-year overall survival rate for patients with FIGO (International Federation of Gynecology and Obstetrics) stage I disease was 56% [7]. Another study that analyzed 84 patients with cervical ACC reported an overall poor prognosis, with a 10-year overall survival rate of only 36.94% [8]. Even in early-stage disease, cervical ACC may exhibit marked aggressiveness with early distant metastasis to the lungs, bones, liver, and other organs [9]. In a previous study, 19 patients with FIGO stage I cervical ACC underwent lymphadenectomy; the lymph node metastasis rate was as high as 74% [10]. The patient described in the present report study underwent radical hysterectomy plus bilateral oophorectomy at an early stage and remained asymptomatic for 10 years postoperatively. She presented with abdominal pain at the time of admission, and contrast-enhanced abdominal CT revealed multiple metastases to the peritoneum and liver. This clinical course differs from that reported in previous studies, suggesting the possibility of late metastasis of cervical ACC. However, due to the lack of regular tumor marker monitoring and imaging follow-up during the 10‑year postoperative period, the dynamic evolution of tumor recurrence and metastasis could not be fully traced, and the specific timing and progression pattern of late metastasis could not be precisely defined. Therefore, conclusions regarding long-term late metastasis in this case should be interpreted with caution. Further accumulation of long-term follow-up data from more cases of cervical ACC is needed to clarify its metastatic pattern and optimal management and surveillance strategies. The major prognostic factors include age, clinical stage, perineural invasion, and margin status [11,12]. One study suggested that age >70 years is an independent poor prognostic factor for cervical ACC, which significantly increases the risk for mortality. Other studies have proposed that anatomical site and clinical stage are the most critical prognostic factors for ACC in the female lower genital tract [13]. Early radical surgery and relatively young age at diagnosis in this patient may have been important factors contributing to late metastasis. Reports describing the imaging features of cervical ACC are extremely rare. Existing studies suggest that its imaging characteristics are similar to those of other malignant cervical tumors without obvious specific differences [14]. Typical magnetic resonance imaging (MRI) findings of this disease include exophytic or endophytic cervical masses that may present as cauliflower-like, nodular, or polypoid lesions, and are mostly characterized by invasive growth. On noncontrast MRI, the lesions exhibit isointense or slightly hypointense signals on T1-weighted imaging (T1WI) and pathognomonic honeycomb-like, sieve-like mixed hyperintense, and hypointense signals on T2WI, with multiple tiny intratumoural cystic changes. After contrast administration, the solid components of the tumor exhibit marked enhancement, while the cystic areas exhibit no enhancement, resulting in an overall grid-like or lace-like enhancement pattern. Some authors have reported that multiple punctate hyperintense foci within the tumor on T2WI, lobulated tumor margins, and internal septation-like structures are helpful imaging features for the preoperative diagnosis of cervical ACC [14]. Pathologically, the punctate hyperintense areas mostly correspond to mucin within the tumor glandular lumens, whereas the lobulated contour and multiple internal septa may correspond with pseudocapsule and interglandular fibrous stroma. In the case described herein, only the MRI report was available without the original imaging data. The report indicated abnormal signals only in the endometrium, suggesting an early-stage lesion. Nevertheless, the final diagnosis of cervical ACC depends on histopathological biopsy findings. The histological features of cervical ACC under microscopic view are highly similar to those of salivary ACC. Histological patterns include cribriform, tubular, and solid types, all of which exhibit invasive growth with prominent stromal reaction, which may present as myxoid change, hyaline change, or desmoplasia, with foci of necrosis also evident within the tumor. The cribriform pattern is the most common histological type. Microscopically, tumor cells form round or oval pseudoglandular spaces of varying sizes, surrounded by an eosinophilic basement membrane-like material both inside and outside the glandular lumen. This material exhibited positive expression on periodic acid–Schiff staining and type IV collagen, laminin, heparan sulfate proteoglycan, and actin antibody staining; moreover, some pseudoglandular lumina may be filled with basophilic granular material [12]. The tubular pattern is composed of single or double layers of tumor cells, with an eosinophilic amorphous material filling the lumen. In the solid pattern, tumor cells are arranged in sheets, irregular nests, cords, and trabeculae and, occasionally, in small clusters, surrounded by a basement membrane-like material [15]. Immunohistochemical staining revealed that basaloid tumor cells of the cervical ACC were positive for broad-spectrum cytokeratin (CKpan), CK7, and CD117 [12]. Due to the extreme rarity of cervical ACC, large-sample prospective studies are lacking, and no unified consensus has been reached on a standardized clinical treatment protocol. Radical surgery is the primary treatment option. For patients with ill-defined tumor boundaries or incomplete resection, radiotherapy can be used as an adjuvant treatment, and most investigators believe that cervical ACC is relatively sensitive to radiotherapy. Some studies have reported that radical surgery combined with adjuvant radiotherapy yields better outcomes than surgery alone [7]. The multiple distant metastases in the present case may be related to the lack of postoperative radiotherapy, and the clinical utility of chemotherapy for cervical ACC is limited [5]. Although it can be used as palliative adjuvant therapy for patients with recurrence or metastasis, no universally accepted standardized chemotherapy regimen has been established to date [16]. Other studies have shown that neither postoperative chemotherapy nor radiotherapy alone can significantly improve overall survival. Only in high-risk subgroups, such as those with stages III–IV disease, positive surgical margins, and perineural invasion, can postoperative concurrent chemoradiotherapy contribute to improved local control, although this benefit has not translated into a clear overall survival advantage [8]. In a study based on the largest pooled data from the published literature (staged according to the 2018 FIGO Gynecological Oncology Staging System), Dixit et al. [17] found significant prognostic differences among different treatment regimens. Among the 14 stage-I patients who underwent radiotherapy alone, 13 (92.9%) achieved disease free status, with a mean follow up of 5.5 years. The disease-free survival rate was 61.5% (8/13) in patients treated with surgery alone. For patients treated with surgery plus adjuvant radiotherapy, the disease-free survival rate was only 50% (3/6), with a mean follow-up of 38 months. Based on these findings, Dixit et al. [17] recommended that early-stage cervical ACC should be treated with surgery combined with adjuvant chemoradiotherapy, whereas advanced-stage disease should be managed using chemoradiotherapy. In the present case, multiple hepatic and peritoneal metastases developed after radical surgery for cervical ACC, requiring a differential diagnosis from the following diseases. First, primary peritoneal serous carcinomas occur mostly in middle-age and elderly women. Its histological features are consistent with those of the same type of tumor, with equivalent differentiation originating from the ovaries. It widely invades the peritoneal surface without involving the ovarian parenchyma, and serum CA125 levels are often significantly elevated. The imaging findings were dominated by massive ascites, multiple nodules in the peritoneum and omentum, and omental caking with no adnexal mass. Second, malignant peritoneal mesothelioma is a rare malignant tumor arising from the peritoneal mesothelial cells and is the most common primary malignant tumor of the peritoneum. It is more frequently observed in middle-age men and is often associated with asbestos exposure. They are classified into the diffuse and localized types, with the diffuse type being the most common. Imaging features include creeping growth along the peritoneal surface and extensive irregular thickening of the peritoneum, omentum, and mesentery with nodules or confluent masses. Lesions may coalesce to encase the abdominopelvic organs. Omental involvement forms an “omental cake,” while mesenteric lesions may present as “stellate” or “pleated” masses. Contrast enhancement was mild to moderate, and massive ascites were frequently observed. Conclusions This case indicates that ACC of the uterine cervix may develop distant metastasis as late as 10 years after the initial diagnosis, without adjuvant radiotherapy or chemotherapy. Clinicians should raise awareness of this disease, strengthen long-term follow-ups, and perform timely imaging evaluations when symptoms occur. Author contributions Yinping Han analyzed data and wrote the manuscript. Junlin Zhou performed the literature search and reviewed the manuscript. All authors read and approved the final manuscript. Ethics approval This study was conducted in accordance with the Declaration of Helsinki. This study was approved by the Medical Ethics Committee of the Second Hospital of Lanzhou University (approval number: 2022A-271) and informed consent was waived. Patient consent A written informed consent was obtained from the patient for the publication of this case report.